Login / Signup

Urine Proteome in Distinguishing Hepatic Steatosis in Patients with Metabolic-Associated Fatty Liver Disease.

Chang-Hai LiuShanshan ZhengShisheng WangDongbo WuWei JiangQingmin ZengYi WeiYong ZhangHong Tang
Published in: Diagnostics (Basel, Switzerland) (2022)
Ceruloplasmin and ORM1 are potential biomarkers in distinguishing mild and severe steatosis in MAFLD patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • insulin resistance
  • early onset
  • high fat diet
  • patient reported outcomes
  • fatty acid
  • adipose tissue